AKT1 and urinary bladder cancer: Since radiation was shown to activate the PI3K/Akt survival/growth pathway which may be responsible for the cell death escape and radioresistance [17], [18], concurrent mTOR inhibition may potentially overcome resistance to radiation in bladder cancer.